Skip to main content
logo
Glenmark Pharmaceuticals Limited (BOM:532296)
India flag India · Delayed Price · Currency is INR
2,232.95
+3.30 (0.15%)
At close: Apr 21, 2026

Glenmark Pharmaceuticals Revenue

Glenmark Pharmaceuticals had revenue of 39.01B INR in the quarter ending December 31, 2025, with 15.15% growth. This brings the company's revenue in the last twelve months to 165.10B, up 18.26% year-over-year. In the fiscal year ending March 31, 2025, Glenmark Pharmaceuticals had annual revenue of 133.63B with 5.68% growth.

Revenue (ttm)
165.10B
Revenue Growth
+18.26%
P/S Ratio
3.82
Revenue / Employee
10.45M
Employees
15,800
Market Cap
630.18B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025133.63B7.18B5.68%
Mar 31, 2024126.45B9.90B8.49%
Mar 31, 2023116.56B-6.49B-5.28%
Mar 31, 2022123.05B13.61B12.44%
Mar 31, 2021109.44B2.87B2.69%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Dr. Reddy's Laboratories345.83B
Lupin261.51B
Torrent Pharmaceuticals127.42B
Jubilant Pharmova79.18B
Abbott India68.24B
Granules India50.92B
J. B. Chemicals & Pharmaceuticals41.93B
GlaxoSmithKline Pharmaceuticals38.01B
Revenue Rankings

Glenmark Pharmaceuticals News

More News